X

Immunizations and College Gameday: A Collaboration of Opportunity for Pharmacy

By: Jordan Kelley, Rachel Strait, Andrew Smelser, Kelsey Stephens, Trey Warnock, Tia Collier BSPS and PharmD Candidates c/o 2017, University of…

eMAR

Assessing Risks versus Benefits in Initiating Triple Antithrombotic Therapy

By: Jacqueline Chirico, PharmD Candidate c/o 2016 - A dilemma that many clinicians face when treating patients with cardiac problems…

eMAR

New FDA Approved Treatment in Patients With Hypoparathyroidism and Hypocalcemia

By: Dimitrios Savva, PharmD Candidate c/o 2016 - Hypoparathyroidism is a rare disease that affects approximately 60,000 people in the…

eMAR

Seeing is Believing: A Look at VEGF Inhibitors for Diabetic Macular Edema

By: Svetlana Akbasheva, Staff Editor, PharmD Candidate c/o 2016 - Diabetes is one of the biggest health problems in the…

eMAR

Is SAM-E an Effective Treatment for Fibromyalgia?

By: Jacqueline Meaney, PharmD [PGY-1 Resident at Gainesville VAMC in Florida] - Fibromyalgia is a syndrome of chronic pain that…

eMAR

Magic Mushrooms: The Future of Smoking Cessation?

By: Maximilian Magun, PharmD Candidate c/o 2016 - While the harm in smoking is well known, quitting is easier said…

eMAR

Understanding and Managing Diabetic Peripheral Neuropathy

By: Tamara Yunusova, Senior Staff Editor - Diabetic peripheral neuropathy (DPN) is a common complication of diabetes, burdening almost 50%…

eMAR

An Aspirin a Day? New Study Assesses Rate of Inappropriate Aspirin Use for Primary Prevention of CVD

By: Svetlana Akbasheva, Staff Writer - Aspirin 81 mg, or “baby” aspirin, has become almost ubiquitously known as being “heart-healthy”…

eMAR

Great Promise for Factor Xa Inhibitor Antidote: Andexanet Alfa

By: Galina Perel, PharmD Candidate c/o 2016 - Andexanet alfa’s has achieved great advancement in part one of the Phase…

eMAR

Smartphone Applications for Pharmacy Students

By: Hayeon Na, PharmD, Co-Copy Editor [Content-focused] - Going through the PharmD curriculum and working as a student pharmacist, I…

eMAR